Log In
Print this Print this

Clottafact, fibrinogen

  Manage Alerts
Collapse Summary General Information
Company LFB S.A.
DescriptionNanofiltered human fibrinogen
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationBleeding
Indication DetailsTreat postpartum hemorrhages
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today